Financhill
Sell
46

AZO Quote, Financials, Valuation and Earnings

Last price:
$3,198.00
Seasonality move :
4.7%
Day range:
$3,206.16 - $3,274.26
52-week range:
$2,510.00 - $3,416.71
Dividend yield:
0%
P/E ratio:
21.76x
P/S ratio:
3.08x
P/B ratio:
--
Volume:
267.2K
Avg. volume:
147.2K
1-year change:
24.78%
Market cap:
$54.7B
Revenue:
$18.5B
EPS (TTM):
$149.54
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Revenue $12.6B $14.6B $16.3B $17.5B $18.5B
Revenue Growth (YoY) 6.48% 15.81% 11.09% 7.41% 5.92%
 
Cost of Revenues $5.9B $6.9B $7.8B $8.4B $8.7B
Gross Profit $6.8B $7.7B $8.5B $9.1B $9.8B
Gross Profit Margin 53.6% 52.76% 52.13% 51.96% 53.09%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $4.4B $4.8B $5.2B $5.6B $6B
Operating Income $2.4B $2.9B $3.3B $3.5B $3.8B
 
Net Interest Expenses $201.2M $195.3M $191.6M $306.4M $451.6M
EBT. Incl. Unusual Items $2.2B $2.7B $3.1B $3.2B $3.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $483.5M $578.9M $649.5M $639.2M $674.7M
Net Income to Company $1.7B $2.2B $2.4B $2.5B $2.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.7B $2.2B $2.4B $2.5B $2.7B
 
Basic EPS (Cont. Ops) $73.62 $97.60 $120.83 $136.60 $153.82
Diluted EPS (Cont. Ops) $71.93 $95.19 $117.19 $132.36 $149.55
Weighted Average Basic Share $23.5M $22.2M $20.1M $18.5M $17.3M
Weighted Average Diluted Share $24.1M $22.8M $20.7M $19.1M $17.8M
 
EBITDA $2.8B $3.4B $3.7B $4B $4.3B
EBIT $2.4B $2.9B $3.3B $3.5B $3.8B
 
Revenue (Reported) $12.6B $14.6B $16.3B $17.5B $18.5B
Operating Income (Reported) $2.4B $2.9B $3.3B $3.5B $3.8B
Operating Income (Adjusted) $2.4B $2.9B $3.3B $3.5B $3.8B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $3.2B $3.7B $4B $4.2B $4.3B
Revenue Growth (YoY) 12.93% 16.32% 8.62% 5.15% 2.13%
 
Cost of Revenues $1.5B $1.7B $2B $2B $2B
Gross Profit $1.7B $1.9B $2B $2.2B $2.3B
Gross Profit Margin 53.12% 52.47% 50.05% 52.84% 53%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.1B $1.2B $1.3B $1.4B $1.4B
Operating Income $615.2M $754.5M $723M $848.6M $841.1M
 
Net Interest Expenses $46.2M $43.3M $57.7M $91.4M $107.6M
EBT. Incl. Unusual Items $569M $711.2M $665.3M $757.2M $733.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $126.6M $156M $126M $163.8M $168.6M
Net Income to Company $442.4M $555.2M $539.3M $593.5M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $442.4M $555.2M $539.3M $593.5M $564.9M
 
Basic EPS (Cont. Ops) $19.05 $26.45 $28.37 $33.51 $33.40
Diluted EPS (Cont. Ops) $18.61 $25.69 $27.45 $32.55 $32.52
Weighted Average Basic Share $23.2M $21M $19M $17.7M $16.9M
Weighted Average Diluted Share $23.8M $21.6M $19.6M $18.2M $17.4M
 
EBITDA $704.8M $854.1M $832.3M $968.8M $841.1M
EBIT $615.2M $754.5M $723M $848.6M $841.1M
 
Revenue (Reported) $3.2B $3.7B $4B $4.2B $4.3B
Operating Income (Reported) $615.2M $754.5M $723M $848.6M $841.1M
Operating Income (Adjusted) $615.2M $754.5M $723M $848.6M $841.1M
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $13B $15.1B $16.6B $17.7B $18.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6B $7.2B $8B $8.4B $8.7B
Gross Profit $6.9B $8B $8.5B $9.3B $9.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $4.4B $4.9B $5.3B $5.7B $6.1B
Operating Income $2.5B $3.1B $3.2B $3.6B $3.8B
 
Net Interest Expenses $203.6M $192.4M $206.1M $340M $467.8M
EBT. Incl. Unusual Items $2.3B $2.9B $3B $3.3B $3.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $504.2M $608.2M $619.5M $677M $679.5M
Net Income to Company $1.8B $2.3B $2.4B $2.6B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $2.3B $2.4B $2.6B $2.6B
 
Basic EPS (Cont. Ops) $78.08 $105.59 $123.11 $142.04 $153.73
Diluted EPS (Cont. Ops) $76.32 $102.82 $119.29 $137.77 $149.54
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $2.9B $3.5B $3.7B $4.1B $4.2B
EBIT $2.5B $3.1B $3.2B $3.6B $3.8B
 
Revenue (Reported) $13B $15.1B $16.6B $17.7B $18.6B
Operating Income (Reported) $2.5B $3.1B $3.2B $3.6B $3.8B
Operating Income (Adjusted) $2.5B $3.1B $3.2B $3.6B $3.8B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Revenue $3.2B $3.7B $4B $4.2B $4.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5B $1.7B $2B $2B $2B
Gross Profit $1.7B $1.9B $2B $2.2B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.1B $1.2B $1.3B $1.4B $1.4B
Operating Income $615.2M $754.5M $723M $848.6M $841.1M
 
Net Interest Expenses $46.2M $43.3M $57.7M $91.4M $107.6M
EBT. Incl. Unusual Items $569M $711.2M $665.3M $757.2M $733.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $126.6M $156M $126M $163.8M $168.6M
Net Income to Company $442.4M $555.2M $539.3M $593.5M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $442.4M $555.2M $539.3M $593.5M $564.9M
 
Basic EPS (Cont. Ops) $19.05 $26.45 $28.37 $33.51 $33.40
Diluted EPS (Cont. Ops) $18.61 $25.69 $27.45 $32.55 $32.52
Weighted Average Basic Share $23.2M $21M $19M $17.7M $16.9M
Weighted Average Diluted Share $23.8M $21.6M $19.6M $18.2M $17.4M
 
EBITDA $704.8M $854.1M $832.3M $968.8M $841.1M
EBIT $615.2M $754.5M $723M $848.6M $841.1M
 
Revenue (Reported) $3.2B $3.7B $4B $4.2B $4.3B
Operating Income (Reported) $615.2M $754.5M $723M $848.6M $841.1M
Operating Income (Adjusted) $615.2M $754.5M $723M $848.6M $841.1M
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Cash and Equivalents $1.8B $1.2B $264.4M $277.1M $298.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $364.8M $378.4M $504.9M $520.4M $545.6M
Inventory $4.5B $4.6B $5.6B $5.8B $6.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $223M $225.8M $220.7M $217.8M $307.8M
Total Current Assets $6.8B $6.4B $6.6B $6.8B $7.3B
 
Property Plant And Equipment $7.1B $7.6B $8.1B $8.6B $9.2B
Long-Term Investments -- -- -- -- --
Goodwill $302.6M $302.6M $302.6M $302.6M $302.6M
Other Intangibles -- -- -- -- --
Other Long-Term Assets $190.6M $181.6M $203.1M $223.2M $242.1M
Total Assets $14.4B $14.5B $15.3B $16B $17.2B
 
Accounts Payable $5.2B $6B $7.3B $7.2B $7.4B
Accrued Expenses $252.5M $259.5M $253.8M $284.7M $301.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $291.3M $326.5M $336.3M $344.2M $382.4M
Other Current Liabilities $65.4M $84M $93.8M $120.1M $161.4M
Total Current Liabilities $6.3B $7.4B $8.6B $8.5B $8.7B
 
Long-Term Debt $5.5B $5.3B $6.1B $7.7B $9B
Capital Leases -- -- -- -- --
Total Liabilities $15.3B $16.3B $18.8B $20.3B $21.9B
 
Common Stock $237K $230K $207K $189K $175K
Other Common Equity Adj -$354.3M -$308M -$300.5M -$190.8M -$361.6M
Common Equity -$878M -$1.8B -$3.5B -$4.3B -$4.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$878M -$1.8B -$3.5B -$4.3B -$4.7B
 
Total Liabilities and Equity $14.4B $14.5B $15.3B $16B $17.2B
Cash and Short Terms $1.8B $1.2B $264.4M $277.1M $298.2M
Total Debt $5.5B $5.3B $6.1B $7.7B $9B
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Cash and Equivalents $1.7B $961.1M $269.8M $283M $304M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $350.9M $379.3M $501.8M $511.9M --
Inventory $4.6B $4.8B $5.6B $5.8B $6.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $193.5M $240.5M $253.8M $387.4M --
Total Current Assets $6.8B $6.3B $6.6B $7B $7.4B
 
Property Plant And Equipment $7.2B $7.6B $8.1B $8.7B --
Long-Term Investments -- -- -- -- --
Goodwill $302.6M $302.6M $302.6M $302.6M --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $206.2M $193.5M $210M $237.2M --
Total Assets $14.6B $14.5B $15.3B $16.3B $17.5B
 
Accounts Payable $5.3B $6.2B $7.3B $7.2B $7.5B
Accrued Expenses $771.4M $965.9M $982.6M $1.2B --
Current Portion Of Long-Term Debt -- $500M -- -- --
Current Portion Of Capital Lease Obligations $246.3M $263.9M $271.7M $288.9M --
Other Current Liabilities -- -- -- -- $8.9B
Total Current Liabilities $6.5B $8.1B $8.7B $8.8B $8.9B
 
Long-Term Debt $5.5B $4.8B $6.3B $8.6B --
Capital Leases -- -- -- -- --
Total Liabilities $15.6B $16.6B $19.2B $21.5B $22.1B
 
Common Stock $238K $231K $208K $190K --
Other Common Equity Adj -$306.9M -$324.3M -$297.3M -$210.4M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$1B -$2.1B -$3.8B -$5.2B -$4.7B
 
Total Liabilities and Equity $14.6B $14.5B $15.3B $16.3B $17.5B
Cash and Short Terms $1.7B $961.1M $269.8M $283M $304M
Total Debt $5.5B $5.3B $6.3B $8.6B --
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Net Income to Stockholders $1.7B $2.2B $2.4B $2.5B $2.7B
Depreciation & Amoritzation $397.5M $407.7M $442.2M $497.6M $549.8M
Stock-Based Compensation $44.8M $56.1M $70.6M $93.1M $106.2M
Change in Accounts Receivable -$58.6M -$11M -$125.7M -$6.7M -$38.3M
Change in Inventories -$184.2M -$138.5M -$1B -$89.2M -$453.1M
Cash From Operations $2.7B $3.5B $3.2B $2.9B $3B
 
Capital Expenditures $457.7M $621.8M $672.4M $796.7M $1.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$497.9M -$601.8M -$648.1M -$876.2M -$1.3B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $1.9B -- $1.4B $2.4B $2.3B
Long-Term Debt Repaid -$552.2M -$309.9M -$567.2M -$881.1M -$1B
Repurchase of Common Stock -$930.9M -$3.4B -$4.4B -$3.7B -$3.1B
Other Financing Activities -$49M -- -$10.7M -$18.2M -$4.2M
Cash From Financing -$643.6M -$3.5B -$3.5B -$2.1B -$1.7B
 
Beginning Cash (CF) $176.3M $1.8B $1.2B $264.4M $277.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B -$583.7M -$907.5M $4.5M $33.9M
Ending Cash (CF) $1.8B $1.2B $264.4M $277.1M $298.2M
 
Levered Free Cash Flow $2.3B $2.9B $2.5B $2.1B $1.9B
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Net Income to Stockholders $740.5M $785.8M $810M $864.8M $902.2M
Depreciation & Amoritzation $125.4M $129.6M $140.9M $158.5M $175.3M
Stock-Based Compensation $12.6M $18.1M $21.6M $30.7M $34.9M
Change in Accounts Receivable -$95.4M -$19.4M -$64.4M -$45M $28.3M
Change in Inventories -$8.9M $23.8M -$334.6M $4M -$99.3M
Cash From Operations $1.4B $1.3B $1.2B $1.1B $1.1B
 
Capital Expenditures $183.8M $246.1M $303M $366.2M $346.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$250M -$243.1M -$287.4M -$397.2M -$370.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $600M -- $70.1M $832.2M $668.7M
Long-Term Debt Repaid $521.6M -$15M -$18.3M -$520.1M -$652.4M
Repurchase of Common Stock -- -$900M -$1000M -$999.6M -$703.7M
Other Financing Activities -$35.2M -- -$7.3M -$11.9M $804K
Cash From Financing $68.5M -$849.2M -$939.7M -$671.8M -$664.8M
 
Beginning Cash (CF) $509.1M $975.6M $263M $274.9M $275.4M
Foreign Exchange Rate Adjustment $6.1M -$217K $369K $3.1M -$12.4M
Additions / Reductions $1.2B $195.9M $967K -$965K $35.2M
Ending Cash (CF) $1.8B $1.2B $264.4M $277.1M $298.2M
 
Levered Free Cash Flow $1.2B $1B $925M $701.8M $723.5M
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Net Income to Stockholders $1.8B $2.3B $2.4B $2.6B --
Depreciation & Amoritzation $397.3M $417.7M $451.9M $508.5M --
Stock-Based Compensation $45.3M $59.9M $75.3M $97M $83.3M
Change in Accounts Receivable -$17.8M -$30.1M -$120.1M -$3.9M --
Change in Inventories -$175.7M -$150.8M -$908M -$71.8M --
Cash From Operations $3B $3.6B $3.2B $3B --
 
Capital Expenditures $471.7M $608.6M $684.5M $917.7M $837.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$517.3M -$582.6M -$671M -$1B --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $1.4B $3.4B --
Long-Term Debt Repaid -$551.6M -$309.8M -$574.1M -$880.7M --
Repurchase of Common Stock -$1.2B -$3.6B -$4.4B -$4.3B --
Other Financing Activities -- -- -$8.1M -$27.1M --
Cash From Financing -$931.3M -$3.7B -$3.3B -$1.9B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B -$702.5M -$694.4M $8M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.5B $3B $2.5B $2.1B --
Period Ending 2021-08-31 2022-08-31 2023-08-31 2024-08-31 2025-08-31
Net Income to Stockholders $2.2B $2.4B $2.5B $2.7B --
Depreciation & Amoritzation $407.7M $442.2M $497.6M $549.8M --
Stock-Based Compensation $56.1M $70.6M $93.1M $106.2M --
Change in Accounts Receivable -$11M -$125.7M -$6.7M -$38.3M --
Change in Inventories -$138.5M -$1B -$89.2M -$453.1M --
Cash From Operations $3.5B $3.2B $2.9B $3B --
 
Capital Expenditures $621.8M $672.4M $796.7M $1.1B --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$601.8M -$648.1M -$876.2M -$1.3B --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1.4B $2.4B $2.3B --
Long-Term Debt Repaid -$309.9M -$567.2M -$881.1M -$1B --
Repurchase of Common Stock -$3.4B -$4.4B -$3.7B -$3.1B --
Other Financing Activities -- -$10.7M -$18.2M -$4.2M --
Cash From Financing -$3.5B -$3.5B -$2.1B -$1.7B --
 
Beginning Cash (CF) $5.4B $2.6B $1.1B $1.1B --
Foreign Exchange Rate Adjustment $4.2M $506K $8.1M -$12.8M --
Additions / Reductions -$583.7M -$907.5M $4.5M $33.9M --
Ending Cash (CF) $4.8B $1.7B $1.1B $1.2B --
 
Levered Free Cash Flow $2.9B $2.5B $2.1B $1.9B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 1.23% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.75% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock